Assembly Biosciences Inc
F:V7B1
Assembly Biosciences Inc
F:V7B1
Price:
3.2
EUR
8.11%
Market Cap:
€52.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Assembly Biosciences Inc
F:V7B1
|
US |
|
E
|
Enwave Corp
DUS:E4U
|
CA |
|
F
|
Federal Home Loan Mortgage Corp
XMUN:FHL
|
US |
|
Tower Resources PLC
LSE:TRP
|
UK |
|
Perimeter Solutions SA
NYSE:PRM
|
LU |
|
S
|
Seagen Inc
F:SGT
|
US |
|
G
|
Gruppo MutuiOnline SpA
F:MNL
|
IT |
Wall St Price Targets
V7B1 Price Targets Summary
Assembly Biosciences Inc
Assembly Biosciences Inc
Wall Street analysts forecast V7B1 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for V7B1 is 5.95 EUR with a low forecast of 4.84 EUR and a high forecast of 7.79 EUR.
Lowest Forecast
Price Target
4.84
EUR
51% Upside
Average Forecast
Price Target
5.95
EUR
86% Upside
Highest Forecast
Price Target
7.79
EUR
144% Upside
Assembly Biosciences Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V7B1's stock price target?
Price Target
5.95
EUR
5.95
EUR
According to Wall Street analysts, the average 1-year price target for V7B1 is 5.95 EUR with a low forecast of 4.84 EUR and a high forecast of 7.79 EUR.
What is the Revenue forecast for Assembly Biosciences Inc?
Projected CAGR
24%
24%
The compound annual growth rate for Revenue over the next 8 years is 24%.
